Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 7:12:678610.
doi: 10.3389/fphys.2021.678610. eCollection 2021.

Increasing Fracture Risk Associates With Plasma Circulating MicroRNAs in Aging People's Sarcopenia

Affiliations

Increasing Fracture Risk Associates With Plasma Circulating MicroRNAs in Aging People's Sarcopenia

Nana He et al. Front Physiol. .

Abstract

Aging generally coincides with a gradual decline in mass and strength of muscles and bone mineral density (BMD). Sarcopenia is closely linked to osteoporosis in the elderly, which can lead to abnormal gait, balance disorders, and dysfunctions, as well as increase in the risks of falls, fractures, weakness, and death. MicroRNAs (miRNAs, miRs) are a kind of short and non-coding RNA molecules but can regulate posttranscriptional protein expression. However, we have known little about their participation in age-associated osteoporosis and sarcopenia. The current study aims to confirm those miRNAs as biomarkers for age-related reduction in muscular atrophy associated with human blood fractures. In our study, 10 fracture-risk-related miRNAs (miR-637, miR-148a-3p, miR-125b-5p, miR-124-3p, miR-122-5p, miR-100-5p, miR-93-5p, miR-21-5p, miR-23a-3p, and miR-24-3p) were analyzed. For the initial screening, we determined the abundance of fracture-risk-associated miRNAs by RT-PCR most frequently detected in enrolled 93 elderly with sarcopenia and non-sarcopenia, respectively. Statistically, the relative expression levels of plasma miR-23a-3p, miR-93-5p, and miR-637 in the sarcopenia group were significantly lower than that in the non-sarcopenia group, while the levels of other miRNAs did not change significantly. Moreover, we showed that the levels of ASM/height2, handgrip strength, and 4-m velocity in the sarcopenia group were significantly lower than in the non-sarcopenia group. Whereafter, we expanded the sample for further detection and analysis and revealed that the levels of plasma miR-23a-3p, miR-93-5p, and miR-637 in the sarcopenia group were significantly lower than that in the non-sarcopenia group, which is consistent with the initial screening experiment. From our analysis, changes in levels of plasma miR-93-5p and miR-637 were dramatically related to ASM/height2. Furthermore, changes in miR-23a and miR-93-5p were significantly affected by ASM/height2 in female individuals, with no significant correlations between miRNAs changes and these diagnostic indexes in male individuals after adjusting sex. The study showed that plasma miRNAs changed in an aging-related sarcopenia manner and were associated with increased fracture risk. In aging patients, plasma miR-23a-3p, miR-93-5p, and miR-637 have the potential as biomarkers of sarcopenia, which can affect the development of physiological dysfunction and may be also used in the fracture risk assessment of these patients.

Keywords: aging; circulating microRNAs; fracture; plasma; sarcopenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Changes in circulating microRNAs in response to sarcopenia in the elderly. The expression level of microRNAs (miRNAs) were normalized using spike-in cel-miR-39. Unpaired t-test was used for these data. *Compared to non-sarcopenia of the elderly; *P < 0.05; n = 20.
FIGURE 2
FIGURE 2
Fracture risk-associated circulating miR-23a-3p, miR-93-5p, and miR-637 decrease in response to sarcopenia in the elderly. The expression level of microRNAs (miRNAs) were normalized using spike-in cel-miR-39. Unpaired t-test was used for these data. *Compared to non-sarcopenia of the elderly; *P < 0.05, **P < 0.01; n = 73.
FIGURE 3
FIGURE 3
Correlation analysis between the changes in (A) miR-23a-3p, (B) miR-93-5p, and (C) miR-637 and ASM/height2 (kg/m2), handgrip strength (kg), and 4-m velocity (m/s). The correlation between the changes in miR-23a-3p, miR-93-5p, and miR-637 and the diagnostic indicators of sarcopenia (ASM/height2, handgrip strength, and 4-m velocity) in sarcopenic and non-sarcopenic subjects. Pearson’s method was used for correlation analyses;*P < 0.05; n = 186.
FIGURE 4
FIGURE 4
Correlation analysis between the changes in (A) miR-23a-3p, (B) miR-93-5p, and (C) miR-637 and ASM/height2 (kg/m2), handgrip strength (kg), and 4-m velocity (m/s) in women. The correlation analysis of miR-23a-3p and miR-93-5p and miR-637 with these indicators in female subjects. Pearson’s method was used for correlation analyses; *P < 0.05; n = 119.
FIGURE 5
FIGURE 5
Correlation analysis between the changes in (A) miR-23a-3p, (B) miR-93-5p, and (C) miR-637 and ASM/height2 (kg/m2), handgrip strength (kg), and 4-m velocity (m/s) in men. The correlation analysis of miR-23a-3p and miR-93-5p and miR-637 with these indicators in male subjects. Pearson’s method was used for correlation analyses; *P < 0.05; n = 67.

References

    1. Andersen G. B., Tost J. (2020). Circulating miRNAs as biomarker in cancer. Recent Results Cancer Res. 215 277–298. 10.1007/978-3-030-26439-0_15 - DOI - PubMed
    1. Anderson L. J., Liu H., Garcia J. M. (2017). Sex differences in muscle wasting. Adv. Exp. Med. Biol. 1043 153–197. 10.1007/978-3-319-70178-3_9 - DOI - PubMed
    1. Angulo J. C., Assar M. E., Rodriguezmanas L. (2016). Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults. Mol. Aspects Med. 50 1–32. - PubMed
    1. Anton S. D., Hida A., Robert M., Andrew L., Solberg L. M., Mainous A. G., et al. (2018). Nutrition and Exercise in Sarcopenia. Curr. Protein Peptide Sci. 19 649–667. - PubMed
    1. Atik O. (2019). There is an association between Sarcopenia, osteoporosis, and the risk of hip fracture. Eklem Hastalik Cerrahisi 30:1. 10.5606/ehc.2019.001 - DOI - PubMed

LinkOut - more resources